UK & Ireland Prostate Brachytherapy Conference 2018
Friday 23rd March 2018
The Spa Hotel, Tunbridge Wells, Kent
ABSTRACT
SLIDES
08.00
Registration
08.45
Welcome Life in a 4d Brachy centre
Sharon Beesley
Monotherapy
Chair: Sharon Beesley
09.10
HDR Monotherapy in the UK – The first thousand
Peter Hoskin
09.25
LDR or HDR as monotherapy in low risk disease
Amit Bahl
09.40
An alternative monotherapy – Are protons better? The US experience
Anthony Zietman
10.10
Coffee; Exhibition/Poster viewing
Managing intermediate and high risk prostate cancer
Chair: Albert Edwards
10.40
Androgen Deprivation in Brachytherapy – Adding efficacy or just toxicity
Carl Salembier
11.00
How best to boost? A panel discussion
LDR (including an update on Ascende RT)
HDR
IMRT
Discussion
Robert Laing
Peter Hoskin
JoeO ’Sullivan
11.45
Will PIVOTAL Boost give us the answers?
Azman Ibrahim
12.00
Use of HDR and permanent seeds in prostate brachytherapy: Current practices and advances
Jose Perez Calatayud
12.30
Lunch; Exhibition/Poster viewing
13.30
Breakout sessions
Physicists / Radiographers
Real-world brachytherapy for physicists and radiographers
Jose Perez Calatayud / Carlos Villalón Arias / Sara Hodgkinson / Emma Bourke
Clinicians
After the cure: Imaging and side effects handling
Carl Salembier / Alastair Henderson / Adrian Barnardo
14.15
Poster presentations
Chair: Kathryn Lees
The effect of bilateral treatment plan symmetry on postoperative dosimetric outcomes in prostate low-dose-rate brachytherapy: a single-institution study
Mohamed Yoosuf AB
An Investigation into Low Dose Rate Prostate Brachytherapy Iodine-125 Seed Damage during a Standard Transurethral Resection of the Prostate
Whitelaw G
Modulation of spatial dose distribution in permanent prostate brachytherapy using sector dosimetry: an analysis of 394 patients from a single institution
Esteve S
Robotic Prostate Biopsy and LDR/HDR Brachytherapy under MRI Guidance: The CoBra Project
Palmer AL
Initial experience using a rectal spacer (SPACE-OAR) with LDR brachytherapy for Prostate cancer
Morris SL
Experience of HDR brachytherapy in Leeds as a salvage treatment for locally relapsed prostate cancer
Slevin F
Characterising the dosimetric quality of 125I LDR prostate implants and assessing inter-operator variability
Awunor O
14.45
Coffee; Exhibition/Poster viewing
Salvage post-brachytherapy – there is something we can offer?